THEMIS MEDICARE LTD.

Vividhmargi Trust, a promoter of Themis Medicare Limited, has revised disclosures regarding the encumbrance of 2,53,17,620 equity shares, representing 27.49% of the total share capital. The encumbrance, a pledge of shares, was created on June 29, 2026, and is in favor of CTL Trusteeship Limited, acting as Debenture Trustee for Kotak Credit Opportunities Fund Trust. This disclosure is made in accordance with SEBI (SAST) Regulations, 2011. The total promoter holding in the company is 6,18,03,990 equity shares, with 40.96% of this holding now encumbered.

Themis Medicare Limited has received a revised disclosure from Vividhmargi Trust regarding the pledge of 2,53,17,620 equity shares, representing 27.49% of the total share capital. The pledge was created on June 29, 2026, in favor of CTL Trusteeship Limited, acting as Debenture Trustee for Kotak Credit Opportunities Fund Trust. This disclosure is made pursuant to SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The trust holds these shares through its three trustees: Mr. Dinesh Shantilal Patel, Mrs. Jayshree Dinesh Patel, and Dr. Sachin Dinesh Patel. The total promoter holding by Vividhmargi Trust is 6,18,03,990 equity shares, with 2,53,17,620 shares (40.96% of promoter holding) now encumbered.

Themis Medicare Limited has announced a revised disclosure regarding the release of pledged shares by its promoter, Vividhmargi Investments Private Limited. On July 8, 2026, 15,00,000 equity shares, representing 1.63% of the total share capital, were released from a pledge. The pledge was originally created for a loan repayment to Bajaj Finance Limited. This event signifies a reduction in promoter encumbrance, with Vividhmargi Investments Private Limited now holding 2,44,29,460 shares, or 26.52% of the company's total share capital, with no shares currently encumbered.

Vividhmargi Investments Pvt Ltd, a promoter of Themis Medicare Ltd, has disclosed the release of encumbrance on 15,00,000 equity shares. The release occurred on July 8, 2026, reducing the promoter's pledged shareholding. This disclosure is made in accordance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Following the release, Vividhmargi Investments Pvt Ltd holds 2,44,29,460 shares, representing 26.52% of the total share capital, with 1.63% of the total share capital now free from encumbrance.

Vividhmargi Trust, a promoter of Themis Medicare Ltd, has disclosed the creation of an encumbrance (pledge) on 2,53,17,620 equity shares, representing 27.49% of the company's total share capital. The pledge was created on June 29, 2026, in favor of CTL Trusteeship Limited, pursuant to a Debenture Trust Deed. This disclosure is made under Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The total promoter holding by Vividhmargi Trust is 6,18,03,990 equity shares, and the encumbered shares constitute 40.96% of this promoter holding. The shares are held in the names of three trustees: Mr. Dinesh Shantilal Patel, Mrs. Jayshree Dinesh Patel, and Dr. Sachin Dinesh Patel.

Themis Medicare Limited has disclosed that Vividhmargi Trust, a promoter, has pledged 2,53,17,620 equity shares, representing 27.49% of the total share capital. This encumbrance was created on June 29, 2026, as a pledge of shares pursuant to a Debenture Trust Deed executed with CTL Trusteeship Limited. The disclosure is made in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The promoter holding in the company is 6,18,03,990 equity shares, with 40.96% of this holding now encumbered. The shares are held in the names of three trustees: Mr. Dinesh Shantilal Patel, Mrs. Jayshree Dinesh Patel, and Dr. Sachin Dinesh Patel.

CTL Trusteeship Limited, acting as debenture trustee, has disclosed an encumbrance on 2,53,17,620 equity shares of Themis Medicare Limited, representing 27.49% of the issued and paid-up share capital. This encumbrance, created by Vividhmargi Trust, is in favor of CTL Trusteeship Limited as security for debentures. The pledge was effective from June 29, 2026. The disclosure is made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The total equity share capital of Themis Medicare Limited remains unchanged at INR 9,21,00,120.

Themis Medicare Ltd has announced the closure of its trading window effective July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will reopen 48 hours after the board of directors declares the un-audited financial results for the quarter ending June 30, 2026. The specific date for the board meeting to consider these results will be communicated separately.

Themis Medicare Limited has responded to an inquiry from BSE regarding an increase in the volume of its securities. The company stated that there are no pending or delayed disclosures of material information as per SEBI regulations. Themis Medicare confirmed that it regularly disseminates relevant information as required. The clarification was issued on June 23rd, 2026, and signed by Managing Director & CEO Sachin D. Patel.

The Board of Directors of 530199, at its meeting on May 28, 2026, approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The Board also recommended a final dividend of Re. 0.50 per equity share (50%) for the financial year ended March 31, 2026, aggregating to ₹4,60,50,060, subject to shareholder approval at the forthcoming Annual General Meeting. Additionally, M/s. R. Nanabhoy & Co. was re-appointed as the Cost Auditor for the Financial Year 2026-27.